Daily pill can double survival time for world’s deadliest cancer, trial shows
Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a “gamechanger” and one of the biggest (…)
Site référencé: The Guardian (Asia Pacific)
3944.jpg?width=140&quality=85&auto=format&fit=max&s=3b43846a257ff075508ffce8a1f47d39, 3944.jpg?width=460&quality=85&auto=format&fit=max&s=7cc9fbebcd71e89831ebf650f0cbb809, 3944.jpg?width=700&quality=85&auto=format&fit=max&s=3205c77dea48b719949e7d6320e5d2ce
The Guardian (Asia Pacific)
Solo-maxxing : gen Z is embracing single life – for a very sad reason
2/06/2026
How England’s largest forest went from commodity to conservation haven
2/06/2026
My father, the German refugee who fought the Nazis as a ‘secret listener’
2/06/2026
Tomorrow Will Be a Palestinian Day review – work that finds a way out of Gaza’s ruins
2/06/2026
Maga influencer Melissa Rein Lively cautioned after admitting assault in London
2/06/2026
Google owner Alphabet to sell $80bn in stock to fund AI spending spree
2/06/2026